An European Patent for LTS’ application relating to an asenapine transdermal therapeutic system (TTS).
Meet the LTS-Team at CPhI Worldwide 2019 from 5 - 7 November in Frankfurt at our booth 121A70.
Our new webinar "Transdermal Therapeutic Systems - Still an attractive technology?!"
Inspection successfully concluded. In September, the German health authorities extended the manufacturer’s authorisation for LTS Lohmann Therapie-Systeme AG (LTS) to include capsules.
10 year’s anniversary of LTS Wichtelgarten